Home » UPC decisions » Local Division » Munich Local Division » LD Munich, March 17, 2025, Order, UPC_CFI_815/2024

LD Munich, March 17, 2025, Order, UPC_CFI_815/2024

2 min Reading time

Key takeaways

With a previous order dated 23 January 2025 (ORD_3866/2025), the Court referred to a previous order from the Central Division Paris in UPC_CFI_367/2023 to indicate that Meril would have unlimited access to the costs application, while restrictions on confidential information would apply to third parties and the public.

With brief dated 3 February 2025, Edwards modified its request to restrict access to the Confidential Information to Meril and their representatives.

The Court granted the amendment of the confidentiality application so that Meril is granted unrestricted access to the cost application while the public is excluded. The Court argued that only the general public`s interest in information must be taken into account when deciding on the application under R. 262.2 RoP so that the requirements for granting a restriction on publication are therefore lowered. Thus, the Court pointed out that Edwards has a legitimate interest in ensuring that fees negotiated individually with representatives remain secret from the public.

Following this granted order, the remaining pending applications of the parties for protection of confidential information are dismissed/rejected.

Division

Local Division Munich, Panel 1

UPC number

UPC_CFI_815/2024

Type of proceedings

Application for confidentiality

Parties

Claimant (Applicant): Edwards Lifesciences Corporation

Defendants: Meril Gmbh; Meril Life Sciences Pvt Ltd.

Patent(s)

EP 3 646 825

Body of legislation / Rules

Rule 262.2 RoP


Was the article helpful?


Categories


Tags

Stay in the loop

Never miss a beat by subscribing to the email newsletter. Please see our Privacy Policy.

* = Required field